RBPWorld - a comprehensive database of RNA Binding Proteins

Drugs target to GSK3B

Drug name	Drug type	Disease/phenotype	Mechanism of action(MoA)	Phase	Status	Source
LITHIUM CARBONATE	Small molecule	bipolar disorder	Glycogen synthase kinase-3 inhibitor	3.0	Terminated	ClinicalTrials
LITHIUM CARBONATE	Small molecule	stroke	Glycogen synthase kinase-3 inhibitor	3.0	Completed	ClinicalTrials
TIDEGLUSIB	Small molecule	autism spectrum disorder	Glycogen synthase kinase-3 beta inhibitor	2.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	schizophrenia	Glycogen synthase kinase-3 inhibitor	4.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	bipolar disorder	Glycogen synthase kinase-3 inhibitor	4.0	Terminated	ClinicalTrials
LITHIUM CARBONATE	Small molecule	small cell lung carcinoma	Glycogen synthase kinase-3 inhibitor	1.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	depressive disorder	Glycogen synthase kinase-3 inhibitor	4.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	treatment resistant depression	Glycogen synthase kinase-3 inhibitor	2.0	Withdrawn	ClinicalTrials
ELRAGLUSIB	Small molecule	lung neoplasm	Glycogen synthase kinase-3 beta inhibitor	1.0	Recruiting	ClinicalTrials
ELRAGLUSIB	Small molecule	pancreatic adenocarcinoma	Glycogen synthase kinase-3 beta inhibitor	1.0	Recruiting	ClinicalTrials
LITHIUM CARBONATE	Small molecule	corticobasal syndrome	Glycogen synthase kinase-3 inhibitor	1.0	Completed	ClinicalTrials
LY-2090314	Small molecule	leukemia	Glycogen synthase kinase-3 beta inhibitor	2.0	Completed	ClinicalTrials
ELRAGLUSIB	Small molecule	pancreatic adenocarcinoma	Glycogen synthase kinase-3 beta inhibitor	2.0	Recruiting	ClinicalTrials
LITHIUM CARBONATE	Small molecule	Niemann-Pick disease type C	Glycogen synthase kinase-3 inhibitor	0.5	Active, not recruiting	ClinicalTrials
LITHIUM CARBONATE	Small molecule	bipolar disorder	Glycogen synthase kinase-3 inhibitor	2.0	Withdrawn	ClinicalTrials
TIDEGLUSIB	Small molecule	Alzheimer disease	Glycogen synthase kinase-3 beta inhibitor	2.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	bipolar disorder	Glycogen synthase kinase-3 inhibitor	4.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	Huntington disease	Glycogen synthase kinase-3 inhibitor	2.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	prostate cancer	Glycogen synthase kinase-3 inhibitor	1.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	Alzheimer disease	Glycogen synthase kinase-3 inhibitor	2.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	alcohol dependence	Glycogen synthase kinase-3 inhibitor	3.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	major depressive disorder	Glycogen synthase kinase-3 inhibitor	3.0	Terminated	ClinicalTrials
TIDEGLUSIB	Small molecule	Alzheimer disease	Glycogen synthase kinase-3 beta inhibitor	1.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	depressive disorder	Glycogen synthase kinase-3 inhibitor	3.0	Completed	ClinicalTrials
ELRAGLUSIB	Small molecule	Malignant Bone Neoplasm	Glycogen synthase kinase-3 beta inhibitor	1.0	Recruiting	ClinicalTrials
LITHIUM CARBONATE	Small molecule	amyotrophic lateral sclerosis	Glycogen synthase kinase-3 inhibitor	2.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	insomnia	Glycogen synthase kinase-3 inhibitor	4.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	frontotemporal dementia	Glycogen synthase kinase-3 inhibitor	2.0	Recruiting	ClinicalTrials
LITHIUM CARBONATE	Small molecule	Central Nervous System Neoplasm	Glycogen synthase kinase-3 inhibitor	1.0	Terminated	ClinicalTrials
LITHIUM CARBONATE	Small molecule	bone fracture	Glycogen synthase kinase-3 inhibitor	2.0	Recruiting	ClinicalTrials
LITHIUM CARBONATE	Small molecule	neuroendocrine neoplasm	Glycogen synthase kinase-3 inhibitor	2.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	Cognitive impairment	Glycogen synthase kinase-3 inhibitor	4.0	Active, not recruiting	ClinicalTrials
LITHIUM CARBONATE	Small molecule	bipolar disorder	Glycogen synthase kinase-3 inhibitor	4.0	Unknown status	ClinicalTrials
LITHIUM CARBONATE	Small molecule	HIV infection	Glycogen synthase kinase-3 inhibitor	4.0	Completed	ClinicalTrials
TIDEGLUSIB	Small molecule	myotonic dystrophy	Glycogen synthase kinase-3 beta inhibitor	2.0	Recruiting	ClinicalTrials
LITHIUM CARBONATE	Small molecule	bipolar disorder	Glycogen synthase kinase-3 inhibitor	4.0	Withdrawn	ClinicalTrials
LITHIUM CITRATE	Small molecule	psychosis	Glycogen synthase kinase-3 inhibitor	4.0	-	ATC
LITHIUM CARBONATE	Small molecule	depressive disorder	Glycogen synthase kinase-3 inhibitor	4.0	Unknown status	ClinicalTrials
LITHIUM CARBONATE	Small molecule	unipolar depression	Glycogen synthase kinase-3 inhibitor	4.0	-	DailyMed
LITHIUM CARBONATE	Small molecule	aggressive behavior	Glycogen synthase kinase-3 inhibitor	3.0	Completed	ClinicalTrials
LITHIUM CITRATE	Small molecule	bipolar I disorder	Glycogen synthase kinase-3 inhibitor	4.0	-	DailyMed
LITHIUM CARBONATE	Small molecule	amyotrophic lateral sclerosis	Glycogen synthase kinase-3 inhibitor	2.0	Terminated	ClinicalTrials
LITHIUM CARBONATE	Small molecule	Spinal cord injury	Glycogen synthase kinase-3 inhibitor	1.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	spinocerebellar ataxia type 2	Glycogen synthase kinase-3 inhibitor	2.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	neutropenia	Glycogen synthase kinase-3 inhibitor	3.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	progressive supranuclear palsy	Glycogen synthase kinase-3 inhibitor	1.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	major depressive disorder	Glycogen synthase kinase-3 inhibitor	1.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	Dementia	Glycogen synthase kinase-3 inhibitor	3.0	Terminated	ClinicalTrials
ELRAGLUSIB	Small molecule	kidney cancer	Glycogen synthase kinase-3 beta inhibitor	1.0	Recruiting	ClinicalTrials
LITHIUM CARBONATE	Small molecule	multiple sclerosis	Glycogen synthase kinase-3 inhibitor	1.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	major depressive disorder	Glycogen synthase kinase-3 inhibitor	3.0	Completed	ClinicalTrials
ELRAGLUSIB	Small molecule	myelofibrosis	Glycogen synthase kinase-3 beta inhibitor	2.0	Recruiting	ClinicalTrials
LITHIUM CARBONATE	Small molecule	brain cancer	Glycogen synthase kinase-3 inhibitor	2.0	Terminated	ClinicalTrials
ELRAGLUSIB	Small molecule	pancreatic adenocarcinoma	Glycogen synthase kinase-3 beta inhibitor	2.0	Active, not recruiting	ClinicalTrials
LITHIUM CARBONATE	Small molecule	spinocerebellar ataxia type 1	Glycogen synthase kinase-3 inhibitor	1.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	bipolar I disorder	Glycogen synthase kinase-3 inhibitor	3.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	bipolar I disorder	Glycogen synthase kinase-3 inhibitor	4.0	-	DailyMed
LITHIUM CARBONATE	Small molecule	medullary thyroid gland carcinoma	Glycogen synthase kinase-3 inhibitor	2.0	Terminated	ClinicalTrials
LITHIUM CARBONATE	Small molecule	bipolar disorder	Glycogen synthase kinase-3 inhibitor	3.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	bipolar disorder	Glycogen synthase kinase-3 inhibitor	1.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	depressive disorder	Glycogen synthase kinase-3 inhibitor	4.0	Terminated	ClinicalTrials
LITHIUM CARBONATE	Small molecule	depressive disorder	Glycogen synthase kinase-3 inhibitor	1.0	Completed	ClinicalTrials
ELRAGLUSIB	Small molecule	breast neoplasm	Glycogen synthase kinase-3 beta inhibitor	1.0	Recruiting	ClinicalTrials
LITHIUM CARBONATE	Small molecule	Spinocerebellar ataxia type 3	Glycogen synthase kinase-3 inhibitor	2.0	Completed	ClinicalTrials
TIDEGLUSIB	Small molecule	myotonic dystrophy	Glycogen synthase kinase-3 beta inhibitor	2.0	Enrolling by invitation	ClinicalTrials
LITHIUM CARBONATE	Small molecule	Acute kidney injury	Glycogen synthase kinase-3 inhibitor	4.0	Unknown status	ClinicalTrials
LITHIUM CARBONATE	Small molecule	Parkinson disease	Glycogen synthase kinase-3 inhibitor	1.0	Active, not recruiting	ClinicalTrials
LITHIUM CARBONATE	Small molecule	major depressive disorder	Glycogen synthase kinase-3 inhibitor	4.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	internal carotid artery stenosis	Glycogen synthase kinase-3 inhibitor	3.0	Recruiting	ClinicalTrials
LITHIUM CARBONATE	Small molecule	major depressive disorder	Glycogen synthase kinase-3 inhibitor	4.0	Terminated	ClinicalTrials
LITHIUM CARBONATE	Small molecule	bipolar disorder	Glycogen synthase kinase-3 inhibitor	3.0	Unknown status	ClinicalTrials
LITHIUM CARBONATE	Small molecule	psychosis	Glycogen synthase kinase-3 inhibitor	4.0	-	ATC
LITHIUM CARBONATE	Small molecule	anxiety	Glycogen synthase kinase-3 inhibitor	3.0	Terminated	ClinicalTrials
LITHIUM CARBONATE	Small molecule	multiple system atrophy	Glycogen synthase kinase-3 inhibitor	2.0	Terminated	ClinicalTrials
LITHIUM CARBONATE	Small molecule	Familial adenomatous polyposis	Glycogen synthase kinase-3 inhibitor	2.0	Enrolling by invitation	ClinicalTrials
LY-2090314	Small molecule	cancer	Glycogen synthase kinase-3 beta inhibitor	1.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	schizophrenia	Glycogen synthase kinase-3 inhibitor	3.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	osteosarcoma	Glycogen synthase kinase-3 inhibitor	4.0	Recruiting	ClinicalTrials
LITHIUM CARBONATE	Small molecule	depressive disorder	Glycogen synthase kinase-3 inhibitor	3.0	Terminated	ClinicalTrials
TIDEGLUSIB	Small molecule	amyotrophic lateral sclerosis	Glycogen synthase kinase-3 beta inhibitor	2.0	Not yet recruiting	ClinicalTrials
ELRAGLUSIB	Small molecule	metastasis	Glycogen synthase kinase-3 beta inhibitor	1.0	Recruiting	ClinicalTrials
LITHIUM CARBONATE	Small molecule	bipolar I disorder	Glycogen synthase kinase-3 inhibitor	4.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	treatment resistant depression	Glycogen synthase kinase-3 inhibitor	3.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	schizophrenia	Glycogen synthase kinase-3 inhibitor	3.0	Terminated	ClinicalTrials
LITHIUM CARBONATE	Small molecule	bipolar disorder	Glycogen synthase kinase-3 inhibitor	4.0	-	DailyMed
ELRAGLUSIB	Small molecule	malignant glioma	Glycogen synthase kinase-3 beta inhibitor	1.0	Recruiting	ClinicalTrials
LITHIUM CARBONATE	Small molecule	depressive disorder	Glycogen synthase kinase-3 inhibitor	2.0	Completed	ClinicalTrials
TIDEGLUSIB	Small molecule	Steinert myotonic dystrophy	Glycogen synthase kinase-3 beta inhibitor	2.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	bipolar I disorder	Glycogen synthase kinase-3 inhibitor	4.0	Unknown status	ClinicalTrials
LITHIUM CARBONATE	Small molecule	bipolar disorder	Glycogen synthase kinase-3 inhibitor	2.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	Spinal cord injury	Glycogen synthase kinase-3 inhibitor	2.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	bipolar I disorder	Glycogen synthase kinase-3 inhibitor	2.0	Completed	ClinicalTrials
LITHIUM CARBONATE	Small molecule	depressive disorder	Glycogen synthase kinase-3 inhibitor	4.0	Recruiting	ClinicalTrials
LITHIUM CARBONATE	Small molecule	anxiety	Glycogen synthase kinase-3 inhibitor	1.0	Withdrawn	ClinicalTrials
LITHIUM CARBONATE	Small molecule	differentiated thyroid carcinoma	Glycogen synthase kinase-3 inhibitor	2.0	Completed	ClinicalTrials
LITHIUM CITRATE	Small molecule	psychosis	Glycogen synthase kinase-3 inhibitor	4.0	-	ATC
LITHIUM CARBONATE	Small molecule	concussion	Glycogen synthase kinase-3 inhibitor	1.0	Withdrawn	ClinicalTrials
ELRAGLUSIB	Small molecule	sarcoma	Glycogen synthase kinase-3 beta inhibitor	1.0	Recruiting	ClinicalTrials
LY-2090314	Small molecule	pancreatic carcinoma	Glycogen synthase kinase-3 beta inhibitor	1.0	Terminated	ClinicalTrials
LITHIUM CARBONATE	Small molecule	autism spectrum disorder	Glycogen synthase kinase-3 inhibitor	3.0	Recruiting	ClinicalTrials
LITHIUM CARBONATE	Small molecule	conduct disorder	Glycogen synthase kinase-3 inhibitor	3.0	Completed	ClinicalTrials
LITHIUM CITRATE	Small molecule	bipolar I disorder	Glycogen synthase kinase-3 inhibitor	4.0	-	DailyMed
LITHIUM CARBONATE	Small molecule	bipolar I disorder	Glycogen synthase kinase-3 inhibitor	4.0	Withdrawn	ClinicalTrials

Welcome to

RBP World!

Drugs target to GSK3B

Targets details